Ventas (VTR) reported earnings 30 days ago. What's next for the stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas NYSE: VTR raised its 2026 investment and earnings outlook after reporting second-quarter growth led by its senior housing operating portfolio, or SHOP, as occupancy gains and rent growth lifted property-level results.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas, Inc. (VTR) Q2 2026 Earnings Call Transcript
VTR beat Q2 FFO and revenue estimates as strong SHOP growth lifts NOI, while senior housing investments drive higher 2026 FFO guidance.
Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.97 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to FFO of $0.87 per share a year ago.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Ventas (VTR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
VTR is expected to have posted higher Q2 revenues and FFO as senior housing demand and OM&R gains offset pressure from triple-net properties.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas is positioned as both a dividend and growth REIT, benefiting from macro tailwinds in senior housing demand. VTR's investment-grade balance sheet, geographic diversity, and expanding portfolio underpin its resilience and modest growth outlook. Despite a rich 23x forward earnings multiple, upside forecasts are only 7%–10%, warranting a more neutral valuation stance.